Millennium Management’s Orgenesis Inc. Common Stock ORGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,000
Closed -$35K 7651
2022
Q1
$35K Sell
1,000
-1,184
-54% -$36K ﹤0.01% 6502
2021
Q4
$63K Sell
2,184
-167
-7% -$6.54K ﹤0.01% 6417
2021
Q3
$116K Sell
2,351
-10,828
-82% -$544K ﹤0.01% 6370
2021
Q2
$668K Buy
13,179
+11,930
+955% +$601K ﹤0.01% 5038
2021
Q1
$72K Buy
+1,249
New +$81.4K ﹤0.01% 5736
2020
Q3
Sell
-2,806
Closed -$171K 4906
2020
Q2
$171K Buy
+2,806
New +$170K ﹤0.01% 3883

Other funds holding ORGS

Millennium Management's ORGS Position: Q2 2022 in Review

Millennium Management sold out of Orgenesis Inc. Common Stock (ORGS) in Q2 2022, closing a stake of 1,000 shares — an estimated $35K sold.

Millennium Management first reported a position in ORGS in Q2 2020 and held it in 6 quarters. The position peaked at $668K in Q2 2021. 21 funds tracked by Wall St. Rank hold ORGS as of Q2 2022.

  • Millennium Management reported no remaining Orgenesis Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Millennium Management sold 1,000 Orgenesis Inc. Common Stock shares in Q2 2022, an estimated $35K.
  • Millennium Management first reported a position in Orgenesis Inc. Common Stock in Q2 2020 and held it in 6 quarters.
  • Millennium Management's Orgenesis Inc. Common Stock position peaked at $668K in Q2 2021.
  • 21 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q2 2022.

Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.